Attempts to immunoprotect adult horses, specifically pregnant mares, with commercial vaccines against clinical disease induced by equine herpesvirus-1.

F. Bürki, N. Nowotny, J. Oulehla, O. Schmehlik, K. Möstl, C. Pallan, E. Rossmanith

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

In a project lasting 4 years more than 300 Lipizzans, around 180 of them adults, were vaccinated systematically against Equine Herpesvirus-1 (EHV-1) and representative groups thereof were serologically controlled for their antibody responses. In part, vaccination intervals recommended on packing slips were followed, in part other intervals, implicated by intermediary results, were used. A live virus vaccine proved ineffective if humoral antibodies were present. An oil-adjuvanted vaccine proved of highest antiviral immunogenicity, but after repeated revaccinations caused severe local reactions so frequently that we had to discontinue its use in adults. Fetal calf serum originating from the cell cultures used for viral propagation and not eliminated from the marketed product, was accused of being responsible for the incompatibilities. An inactivated mixed virus vaccine was of weak antigenicity regarding its EHV-1 component (whereas good regarding the influenza viruses) so that it proved unsatisfactory for primary immunization. It was, however, potent enough, and clinically well tolerated, to maintain suitable antibody levels in horses which had been initially primed by the oil-adjuvanted vaccine. Consequently, optimal humoral immunity as well as clinical acceptability resulted when two different vaccines were used, one for induction, the other for maintenance of protection. Vaccination intervals different from those on the packing slips are recommended for the mixed vaccine.

Original languageEnglish
Pages (from-to)432-440
Number of pages9
JournalZentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B
Volume38
Issue number6
Publication statusPublished - Aug 1991

Fingerprint

Equid Herpesvirus 1
Equid herpesvirus 1
mares
Horses
Vaccines
vaccines
horses
antibodies
Oils
Vaccination
vaccination
Viruses
Secondary Immunization
oils
viruses
Antibodies
fetal bovine serum
Orthomyxoviridae
Humoral Immunity
humoral immunity

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Attempts to immunoprotect adult horses, specifically pregnant mares, with commercial vaccines against clinical disease induced by equine herpesvirus-1. / Bürki, F.; Nowotny, N.; Oulehla, J.; Schmehlik, O.; Möstl, K.; Pallan, C.; Rossmanith, E.

In: Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B, Vol. 38, No. 6, 08.1991, p. 432-440.

Research output: Contribution to journalArticle

@article{824dba63e3394798a9f5384d97ae936b,
title = "Attempts to immunoprotect adult horses, specifically pregnant mares, with commercial vaccines against clinical disease induced by equine herpesvirus-1.",
abstract = "In a project lasting 4 years more than 300 Lipizzans, around 180 of them adults, were vaccinated systematically against Equine Herpesvirus-1 (EHV-1) and representative groups thereof were serologically controlled for their antibody responses. In part, vaccination intervals recommended on packing slips were followed, in part other intervals, implicated by intermediary results, were used. A live virus vaccine proved ineffective if humoral antibodies were present. An oil-adjuvanted vaccine proved of highest antiviral immunogenicity, but after repeated revaccinations caused severe local reactions so frequently that we had to discontinue its use in adults. Fetal calf serum originating from the cell cultures used for viral propagation and not eliminated from the marketed product, was accused of being responsible for the incompatibilities. An inactivated mixed virus vaccine was of weak antigenicity regarding its EHV-1 component (whereas good regarding the influenza viruses) so that it proved unsatisfactory for primary immunization. It was, however, potent enough, and clinically well tolerated, to maintain suitable antibody levels in horses which had been initially primed by the oil-adjuvanted vaccine. Consequently, optimal humoral immunity as well as clinical acceptability resulted when two different vaccines were used, one for induction, the other for maintenance of protection. Vaccination intervals different from those on the packing slips are recommended for the mixed vaccine.",
author = "F. B{\"u}rki and N. Nowotny and J. Oulehla and O. Schmehlik and K. M{\"o}stl and C. Pallan and E. Rossmanith",
year = "1991",
month = "8",
language = "English",
volume = "38",
pages = "432--440",
journal = "Journal of Veterinary Medicine Series B: Infectious Diseases and Veterinary Public Health",
issn = "1863-1959",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Attempts to immunoprotect adult horses, specifically pregnant mares, with commercial vaccines against clinical disease induced by equine herpesvirus-1.

AU - Bürki, F.

AU - Nowotny, N.

AU - Oulehla, J.

AU - Schmehlik, O.

AU - Möstl, K.

AU - Pallan, C.

AU - Rossmanith, E.

PY - 1991/8

Y1 - 1991/8

N2 - In a project lasting 4 years more than 300 Lipizzans, around 180 of them adults, were vaccinated systematically against Equine Herpesvirus-1 (EHV-1) and representative groups thereof were serologically controlled for their antibody responses. In part, vaccination intervals recommended on packing slips were followed, in part other intervals, implicated by intermediary results, were used. A live virus vaccine proved ineffective if humoral antibodies were present. An oil-adjuvanted vaccine proved of highest antiviral immunogenicity, but after repeated revaccinations caused severe local reactions so frequently that we had to discontinue its use in adults. Fetal calf serum originating from the cell cultures used for viral propagation and not eliminated from the marketed product, was accused of being responsible for the incompatibilities. An inactivated mixed virus vaccine was of weak antigenicity regarding its EHV-1 component (whereas good regarding the influenza viruses) so that it proved unsatisfactory for primary immunization. It was, however, potent enough, and clinically well tolerated, to maintain suitable antibody levels in horses which had been initially primed by the oil-adjuvanted vaccine. Consequently, optimal humoral immunity as well as clinical acceptability resulted when two different vaccines were used, one for induction, the other for maintenance of protection. Vaccination intervals different from those on the packing slips are recommended for the mixed vaccine.

AB - In a project lasting 4 years more than 300 Lipizzans, around 180 of them adults, were vaccinated systematically against Equine Herpesvirus-1 (EHV-1) and representative groups thereof were serologically controlled for their antibody responses. In part, vaccination intervals recommended on packing slips were followed, in part other intervals, implicated by intermediary results, were used. A live virus vaccine proved ineffective if humoral antibodies were present. An oil-adjuvanted vaccine proved of highest antiviral immunogenicity, but after repeated revaccinations caused severe local reactions so frequently that we had to discontinue its use in adults. Fetal calf serum originating from the cell cultures used for viral propagation and not eliminated from the marketed product, was accused of being responsible for the incompatibilities. An inactivated mixed virus vaccine was of weak antigenicity regarding its EHV-1 component (whereas good regarding the influenza viruses) so that it proved unsatisfactory for primary immunization. It was, however, potent enough, and clinically well tolerated, to maintain suitable antibody levels in horses which had been initially primed by the oil-adjuvanted vaccine. Consequently, optimal humoral immunity as well as clinical acceptability resulted when two different vaccines were used, one for induction, the other for maintenance of protection. Vaccination intervals different from those on the packing slips are recommended for the mixed vaccine.

UR - http://www.scopus.com/inward/record.url?scp=0026210060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026210060&partnerID=8YFLogxK

M3 - Article

VL - 38

SP - 432

EP - 440

JO - Journal of Veterinary Medicine Series B: Infectious Diseases and Veterinary Public Health

JF - Journal of Veterinary Medicine Series B: Infectious Diseases and Veterinary Public Health

SN - 1863-1959

IS - 6

ER -